Page last updated: 2024-09-03

sr 33557 and Leukemia P388

sr 33557 has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bordier, C; Chen, KG; Durán, GE; Jaffrézou, JP; Laurent, G; Levade, T; Muller, C; Sikic, BI	1
Chatelain, P; Jaffrézou, JP; Laurent, G; Levade, T	1

Other Studies

2 other study(ies) available for sr 33557 and Leukemia P388

Article	Year
Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochimica et biophysica acta, 1995, 04-06, Volume: 1266, Issue:1 Topics: Affinity Labels; Animals; Desipramine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Indolizines; Leukemia P388; Lysosomes; Mianserin; Mice; Phenethylamines; Rhodamine 123; Rhodamines; Sphingomyelin Phosphodiesterase; Trimipramine; Tumor Cells, Cultured; Vasodilator Agents; Vinblastine	1995
Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine. Cancer research, 1992, Dec-01, Volume: 52, Issue:23 Topics: Animals; Doxorubicin; Drug Resistance; Hydrolysis; Indolizines; Leukemia P388; Mice; Microscopy, Electron; Microscopy, Fluorescence; Phenethylamines; Sphingomyelins; Tumor Cells, Cultured; Vacuoles	1992

Article

Year

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.

Biochimica et biophysica acta, 1995, 04-06, Volume: 1266, Issue:1

Topics: Affinity Labels; Animals; Desipramine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Indolizines; Leukemia P388; Lysosomes; Mianserin; Mice; Phenethylamines; Rhodamine 123; Rhodamines; Sphingomyelin Phosphodiesterase; Trimipramine; Tumor Cells, Cultured; Vasodilator Agents; Vinblastine

1995

Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.

Cancer research, 1992, Dec-01, Volume: 52, Issue:23

Topics: Animals; Doxorubicin; Drug Resistance; Hydrolysis; Indolizines; Leukemia P388; Mice; Microscopy, Electron; Microscopy, Fluorescence; Phenethylamines; Sphingomyelins; Tumor Cells, Cultured; Vacuoles

1992